The radiation and medical technology company Eckert & Ziegler has officially inaugurated its new 1,700 square meter operational buildings in Dresden. With this expansion, the company is making a strong statement about its growth ambitions in the region and highlighting the importance of Saxony as an emerging center for radiopharmacy in Europe.

The new building is evidence of Eckert & Ziegler's growth success in the region, but also of the favorable conditions that this location offers," emphasized Saxon Minister of Economic Affairs Martin Dulig (SPD) at the opening ceremony. He praised the company for its contribution to developing Saxony into a leading hub in nuclear medicine.

The company produces highly specialized facilities for the manufacture of radiopharmaceuticals and exports them worldwide at the Dresden-Rossendorf site. Additionally, Eckert & Ziegler offers services for the handling and disposal of radioactive products in cancer medicine there. The company plans to invest up to 50 million euros in the expansion of the production site.

Here is the translation of the heading:

"The newly completed constructions form the basis for the further expansion of Eckert & Ziegler in the region. According to the city of Dresden, the expansion is expected to create up to 100 highly qualified jobs in plant engineering and radiopharmacy. This not only strengthens the local economy but also solidifies Saxony's position as an important location for medical innovations.